Predicting neurodevelopmental outcomes in neonatal abstinence syndrome
The purpose of this study is to find whether an MRI of the brain can help identify which infants will have withdrawal symptoms after having been exposed to opioids prenatally.
The purpose of this study is to identify early functional MRI differences in infants with NAS compared to healthy controls; and to identify associations between brain functional connectivity in infants with NAS and neurodevelopmental outcomes at 6 months.
Participants will be compensated for their participation.
- IRB Number: 1805384405
- Research Study Identifier: TX8943
- Principal Investigator: Rupa Radhakrishnan, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required